Birgitte Rønø's profile picture

Birgitte Rønø

Chief Scientific Officer at Evaxion Biotech

Birgitte Rønø is the current Chief Scientific Officer at Evaxion Biotech. Prior to their current position, they worked as a Specialist for Diabetes Complication Research at Novo Nordisk from March 2013 to April 2017. During their time at Novo Nordisk, they were responsible for outlining, driving and implementing a pre-clinical strategy within the disease area. Additionally, they were a member of a cross-functional target innovation team and managed discovery projects. Some of their key achievements include project endorsement from top management and the implementation of a pre-clinical strategy for Diabetes Complication Research.

Birgitte Rønø has a PhD in Human Biology from Københavns Universitet - University of Copenhagen. Birgitte also has a Master of Science (MSc) in Human Biology from Københavns Universitet - University of Copenhagen.

Some of their coworkers include Jesper Nyegaard Nissen - COO, Jens Kringelum - Director, Genomic Immuno-Oncology, and Bo Karmark - CFO. Birgitte Rønø reports to Lars Wegner, CEO.

Links


Org chart



  1. This content will be removed shortly.